Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
2000000 participants
OBSERVATIONAL
2021-09-13
2036-09-13
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Investigating the Feasibility and Implementation of Whole Genome Sequencing in Patients With Suspected Genetic Disorder
NCT03829176
North Carolina Newborn Exome Sequencing for Universal Screening
NCT02826694
Use of Long Read Genome Sequencing in Patients Suffering From Neurodevelopmental Troubles
NCT05643274
Observational Study of Advanced Data Analytics in Genetic Conditions
NCT05657405
Genetic Analysis of Uncommon Disease Presentations in Non-US Populations
NCT06595940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Institutional membership in HRN will consist of Helix and member healthcare systems (herein referred to as "HRN Member Site(s)"). The Helix Research Network is a multi-center research program that will enroll an unlimited number of participants. Participants will be recruited concurrently from HRN Member Sites. In some cases, HRN Member Sites may recruit participants from multiple clinical sites. Participants who meet the enrollment criteria established in this protocol will be enrolled if they or their legally authorized representative(s) provide informed consent in accordance with all applicable regulations and sIRB requirements. Participants will be enrolled until withdrawal from the study or end of the study. Participants may be recruited at any point during the study period, until the recruitment goals established by the protocol are met.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exome sequencing
Exome sequencing will be completed on each sample submitted.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to comply with all aspects of the protocol
Exclusion Criteria
* History of allogenic stem cell transplant
* Anything that would place the individual at increased risk or preclude an individual's: 1) full compliance with study requirements; or 2) completion of the study based on the assessment from local consenting and enrolling Investigators.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of South Carolina
OTHER
HealthPartners Institute
OTHER
Memorial Hermann Health System
OTHER
WellSpan Health
OTHER
St. Luke's Hospital and Health Network, Pennsylvania
OTHER
Sanford Health
OTHER
Renown Health
OTHER
WakeMed Health and Hospitals
OTHER
University of Nebraska
OTHER
Ohio State University
OTHER
Cone Health
OTHER
Parkview Health
OTHER
Rochester Regional Health
UNKNOWN
University Health Network, Toronto
OTHER
Helix, Inc
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Lee, PhD
Role: PRINCIPAL_INVESTIGATOR
Helix, Inc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Parkview Health
Fort Wayne, Indiana, United States
HealthPartners (myGenetics)
Bloomington, Minnesota, United States
Nebraska Medicine - University of Nebraska Medical Center (Genetic Insights Project)
Omaha, Nebraska, United States
Rochester Regional Health
Rochester, New York, United States
Cone Health (Gene Connect)
Burlington, North Carolina, United States
WakeMed (PreciselyYou)
Raleigh, North Carolina, United States
TriHealth
Cincinnati, Ohio, United States
The Ohio State University (Genomic Health)
Columbus, Ohio, United States
St. Luke's University Health Network (DNAanswers)
Bethlehem, Pennsylvania, United States
WellSpan Health (The Gene Health Project)
York, Pennsylvania, United States
Medical University of South Carolina (In Our DNA SC)
Charleston, South Carolina, United States
Sanford Health (Imagine You)
Sioux Falls, South Dakota, United States
Memorial Hermann Health System (genoME)
Houston, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRN 001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.